Decoy Therapeutics secures up-to-$21M PIPE to push lead asset into trials
Decoy Therapeutics announced a private placement financing (PIPE) with a single healthcare investor, expected to raise about $3.5 million upfront and up to $21 million total through milestone-based warrants. Proceeds are destined to advance Decoy's lead asset into clinical trials, leveraging its D-MAVs platform. The deal features milestone-triggered warrants that could dilute existing shareholders if exercised.
View signal analysis